These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 26685851)
1. The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer. Zer A; Domachevsky L; Rapson Y; Nidam M; Flex D; Allen AM; Stemmer SM; Groshar D; Bernstine H Eur Radiol; 2016 Sep; 26(9):3155-61. PubMed ID: 26685851 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of metabolic parameters measured by Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157 [TBL] [Abstract][Full Text] [Related]
3. The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC. Agüloğlu N; Aksu A; Unat DS; Akyol M Nucl Med Commun; 2022 Dec; 43(12):1217-1224. PubMed ID: 36345766 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related]
5. Volumetric parameters from [ Langen Stokmo H; Aly M; Bowitz Lothe IM; Borja AJ; Mehdizadeh Seraj S; Ghorpade R; Miao X; Hjortland GO; Malinen E; Sorbye H; Werner TJ; Alavi A; Revheim ME J Neuroendocrinol; 2022 Jul; 34(7):e13170. PubMed ID: 35729738 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer]. Ding CY; Guo Z; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289 [No Abstract] [Full Text] [Related]
8. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341 [TBL] [Abstract][Full Text] [Related]
9. Primary tumor standardized uptake value (SUVmax) measured on Hui Z; Wei F; Ren H; Xu W; Ren X J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Lee JW; Choi JS; Lyu J; Lee SM Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001 [TBL] [Abstract][Full Text] [Related]
13. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828 [TBL] [Abstract][Full Text] [Related]
15. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma. Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054 [TBL] [Abstract][Full Text] [Related]
16. The prognostic role of PET/CT in small-cell lung cancer. Budak E; Yanarateş A; Akgün A Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):9-13. PubMed ID: 31865009 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of baseline Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Values of Baseline Zhou Y; Zhang X; Qin H; Zhao Z; Li J; Zhang B; Sang S; Wu Y; Deng S Biomed Res Int; 2020; 2020():9746716. PubMed ID: 32185229 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy. Watanabe M; Nakamoto Y; Ishimori T; Saga T; Kido A; Hamanishi J; Hamanaka Y; Togashi K Ann Nucl Med; 2020 Feb; 34(2):128-135. PubMed ID: 31768818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]